Pgiam/iStock via Getty Images Investment Update Following my last publication on AdaptHealth Corp (NASDAQ:AHCO) in August last year, where I reiterated a hold rating (after revising this lower in June), shares are 20% in the red and trade at ~10x trailing earnings. That report, titled "A 4% return on capital doesn't sing undervalued" covered the relevant points and challenges to AHCO's investment debate, namely:  AHCO is a capital-intensive producing <10% return on capital, and "this has translated into ...